HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
He visited the HTL4 production unit, the IR&D and met our President.
(Report begins at 2:25).
Many thanks to the teams who contributed to the success of this shoot: Charles, Maxime, Mercedes, Victor, Manuella and Louison.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.
The European Society of Cataract and Refractive Surgeons (ESCRS) is a unique opportunity each year to connect with our clients and partners while gaining insights into the key trends shaping the future of ophthalmology.